Author

H. Jespersen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

J. A. Nilsson· 2 shared J. Karlsson· 2 shared L. M. Nilsson· 2 shared L. Ny· 2 shared V. R. Sah· 2 shared B. Einarsdottir· 1 shared C. All-Eriksson· 1 shared E. Larsson· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. A. Nilsson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma

V. R. Sah, H. Jespersen, J. Karlsson, M. Lindberg, L. M. Nilsson, L. Ny, J. A. Nilsson

This study investigates enhancing PD-1 inhibitor efficacy in uveal melanoma through epigenetic modulation with HDAC or BET inhibitors, finding that HDAC inhibition synergizes with immunotherapy.

bioRxiv · Feb 4, 2021Cancer Biology

Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma

J. Karlsson, L. M. Nilsson, E. M. Forsberg, S. Mitra, S. Alsen, G. Shelke, V. R. Sah, U. Stierner, C. All-Eriksson, B. Einarsdottir, H. Jespersen, L. Ny, P. Lindner, E. Larsson, R. Olofsson Bagge, J. A. Nilsson

This study profiles genomic and transcriptomic features of metastatic uveal melanoma, identifying BAP1 inactivation and immune checkpoint receptor expression in tumor-infiltrating lymphocytes.

bioRxiv · Aug 21, 2019Cancer Biology